278 related articles for article (PubMed ID: 15110907)
1. Adrenocorticotropic hormone, blood pressure, and serum erythropoietin concentrations in the rat.
Zhang Y; Andrews MC; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 May; 17(5 Pt 1):457-61. PubMed ID: 15110907
[TBL] [Abstract][Full Text] [Related]
2. Aspirin prevents and partially reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Miao Y; Whitworth JA
Am J Hypertens; 2007 Nov; 20(11):1222-8. PubMed ID: 17954371
[TBL] [Abstract][Full Text] [Related]
3. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat.
Miao Y; Zhang Y; Lim PS; Kanjanapan Y; Mori TA; Croft KD; Earl J; Lee SY; McKenzie KU; Hu L; Whitworth JA
Am J Hypertens; 2007 Mar; 20(3):304-10. PubMed ID: 17324744
[TBL] [Abstract][Full Text] [Related]
4. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
[TBL] [Abstract][Full Text] [Related]
5. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
Zhang Y; Croft KD; Mori TA; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin prevented and partially reversed adrenocorticotropic hormone-induced hypertension in the rat.
Mondo CK; Yang WS; Su JZ; Huang TG
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):369-73. PubMed ID: 16620303
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid metabolism in glucocorticoid-induced hypertension.
Zhang Y; Hu L; Mori TA; Barden A; Croft KD; Whitworth JA
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):557-62. PubMed ID: 18067589
[TBL] [Abstract][Full Text] [Related]
8. The glucocorticoid receptor is required for experimental adrenocorticotrophic hormone-induced hypertension in mice.
Zhang Y; Schyvens CG; Cole TJ; McKenzie KU; Vickers JJ; Whitworth JA
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1044-8. PubMed ID: 20659135
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
Singh A; Eckardt KU; Zimmermann A; Götz KH; Hamann M; Ratcliffe PJ; Kurtz A; Reinhart WH
J Clin Invest; 1993 Jan; 91(1):251-6. PubMed ID: 8423222
[TBL] [Abstract][Full Text] [Related]
10. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat.
Hu L; Zhang Y; Lim PS; Miao Y; Tan C; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2006 Apr; 19(4):413-8. PubMed ID: 16580579
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the rat.
Mondo CK; Zhang Y; de Macedo Possamai V; Miao Y; Schyvens CG; McKenzie KU; Hu L; Guo Z; Whitworth JA
Clin Exp Hypertens; 2006 Feb; 28(2):73-84. PubMed ID: 16546835
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats.
Schyvens CG; Andrews MC; Tam R; Mori TA; Croft KD; McKenzie KU; Whitworth JA; Zhang Y
Clin Exp Hypertens; 2007 Oct; 29(7):465-78. PubMed ID: 17994356
[TBL] [Abstract][Full Text] [Related]
14. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamics of dexamethasone-induced hypertension in the rat.
Ong SL; Zhang Y; Sutton M; Whitworth JA
Hypertens Res; 2009 Oct; 32(10):889-94. PubMed ID: 19644504
[TBL] [Abstract][Full Text] [Related]
16. Prevention of erythropoietin-associated hypertension.
Lee MS; Lee JS; Lee JY
Hypertension; 2007 Aug; 50(2):439-45. PubMed ID: 17548719
[TBL] [Abstract][Full Text] [Related]
17. Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension.
Thida M; Earl J; Zhao Y; Wang H; Tse CS; Vickers JJ; Sutton M; Ong SL; Mori TA; Croft KD; Whitworth JA; Zhang Y
Am J Hypertens; 2010 May; 23(5):569-74. PubMed ID: 20186125
[TBL] [Abstract][Full Text] [Related]
18. Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats.
Sankaralingam S; Desai KM; Glaeser H; Kim RB; Wilson TW
Am J Hypertens; 2006 Nov; 19(11):1174-80. PubMed ID: 17070431
[TBL] [Abstract][Full Text] [Related]
19. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
